We just received data on a new analyst forecast for $NUVL. Anupam Rama from JP Morgan set a price target of 145.0 for NUVL.
To track analyst ratings and price targets for $NUVL, check out Quiver Quantitative's $NUVL forecast page.
Should you buy $NUVL?
Some analysts are better than others. To view the past performance of JP Morgan, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$NUVL Price Targets
Multiple analysts have issued price targets for $NUVL recently. We have seen 15 analysts offer price targets for $NUVL in the last 6 months, with a median target of $135.0.
Here are some recent targets:
- Anupam Rama from JP Morgan set a target price of $145.0 on 12/19/2025
- Gregory Renza from Truist Securities set a target price of $140.0 on 11/24/2025
- Colleen Kusy from Baird set a target price of $158.0 on 11/18/2025
- Richard Law from Goldman Sachs set a target price of $135.0 on 11/18/2025
- Brad Canino from Guggenheim set a target price of $155.0 on 11/18/2025
- Andrew Berens from Leerink Partners set a target price of $149.0 on 11/17/2025
- Laura Prendergast from Stifel set a target price of $135.0 on 11/17/2025
$NUVL Insider Trading Activity
$NUVL insiders have traded $NUVL stock on the open market 105 times in the past 6 months. Of those trades, 0 have been purchases and 105 have been sales.
Here’s a breakdown of recent trading of $NUVL stock by insiders over the last 6 months:
- JAMES E FLYNN has made 0 purchases and 2 sales selling 742,574 shares for an estimated $70,874,975.
- ALEXANDRA BALCOM (Chief Financial Officer) has made 0 purchases and 28 sales selling 157,084 shares for an estimated $13,834,548.
- JAMES RICHARD PORTER (President and CEO) has made 0 purchases and 14 sales selling 108,000 shares for an estimated $8,839,820.
- DEBORAH ANN MILLER (Chief Legal Officer) has made 0 purchases and 16 sales selling 79,000 shares for an estimated $7,816,782.
- MATTHEW SHAIR has made 0 purchases and 12 sales selling 67,500 shares for an estimated $6,835,738.
- HENRY E. PELISH (Chief Scientific Officer) has made 0 purchases and 13 sales selling 51,945 shares for an estimated $4,355,603.
- DARLENE NOCI (Chief Development Officer) has made 0 purchases and 20 sales selling 24,000 shares for an estimated $2,113,021.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NUVL Hedge Fund Activity
We have seen 102 institutional investors add shares of $NUVL stock to their portfolio, and 112 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC removed 1,447,267 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $125,159,650
- RA CAPITAL MANAGEMENT, L.P. added 1,246,456 shares (+inf%) to their portfolio in Q3 2025, for an estimated $107,793,514
- WELLINGTON MANAGEMENT GROUP LLP added 724,491 shares (+46.0%) to their portfolio in Q3 2025, for an estimated $62,653,981
- LOGOS GLOBAL MANAGEMENT LP removed 500,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $38,150,000
- JPMORGAN CHASE & CO added 476,822 shares (+39.8%) to their portfolio in Q3 2025, for an estimated $41,235,566
- BOXER CAPITAL MANAGEMENT, LLC removed 450,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $34,335,000
- JANUS HENDERSON GROUP PLC added 406,093 shares (+22.8%) to their portfolio in Q3 2025, for an estimated $35,118,922
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.